These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


103 related items for PubMed ID: 6507528

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Termination of very early pregnancy by vaginal suppositories-(15S)-15-methyl prostaglandin F2 alpha methyl ester.
    Wan LS, Stiber AJ, Turkel J.
    Contraception; 1981 Dec; 24(6):603-15. PubMed ID: 6173156
    [Abstract] [Full Text] [Related]

  • 4. Termination of early gestation with (15S)-15-methyl prostaglandin F2 alpha methyl ester vaginal suppositories.
    Marrs RP, Brenner PF, Roy S, Mishell DR.
    Contraception; 1981 Dec; 24(6):617-30. PubMed ID: 6173157
    [Abstract] [Full Text] [Related]

  • 5. Termination of early gestation with a single vaginal suppository of (15S)-15-methyl-prostaglandin F2alpha methyl ester.
    Roy S, Brenner PF, Marrs RP, Mishell DR.
    Contraception; 1980 Aug; 22(2):137-52. PubMed ID: 7449379
    [Abstract] [Full Text] [Related]

  • 6. Menstrual regulation with prostaglandin (Pg ONO 802) in Indonesia.
    Agoestina T, Sastrawinata S, Prayitno W, Gonta P.
    Int J Gynaecol Obstet; 1984 Oct; 22(5):403-9. PubMed ID: 6151928
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vaginal administration of 15-methyl-PGF2 alpha methyl ester for preoperative cervical dilatation. Task force on prostaglandins for fertility regulation. The World Health Organization.
    Contraception; 1981 Mar; 23(3):251-9. PubMed ID: 7016432
    [Abstract] [Full Text] [Related]

  • 9. Menses induction and second-trimester pregnancy termination using a polymeric controlled release vaginal delivery system containing (15S)15-methyl PGF2 alpha methyl ester.
    Bygdeman M, Christenssen N, Gréen K, Vesterqvist O, Roseman TJ, Tuttle ME, Spilman CH.
    Contraception; 1983 Feb; 27(2):141-51. PubMed ID: 6303690
    [Abstract] [Full Text] [Related]

  • 10. Termination of second trimester pregnancy with a long-acting vaginal pessary containing 15-methyl-PGF2 alpha methyl ester.
    Int J Gynaecol Obstet; 1983 Apr; 21(2):159-65. PubMed ID: 6136437
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
    Borten M, DiLeo LA, Friedman EA.
    Am J Obstet Gynecol; 1984 Nov 01; 150(5 Pt 1):561-5. PubMed ID: 6496588
    [Abstract] [Full Text] [Related]

  • 13. Interruption of pregnancy with vaginal suppositories containing 16,16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester.
    Wagatsuma T, Tabuchi T, Tabei T, Kaku R.
    Contraception; 1979 Jun 01; 19(6):591-7. PubMed ID: 487809
    [Abstract] [Full Text] [Related]

  • 14. Midtrimester abortion with intravenous administration of 15 methyl prostaglandin F2 alpha.
    Mapa MK, Kochhar U, Raghavan KS, Devi PK.
    Int J Gynaecol Obstet; 1982 Apr 01; 20(2):125-8. PubMed ID: 6125431
    [Abstract] [Full Text] [Related]

  • 15. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
    Bolognese RJ, Corson SL.
    Fertil Steril; 1975 Jul 01; 26(7):695-9. PubMed ID: 1149900
    [Abstract] [Full Text] [Related]

  • 16. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
    Rodger MW, Baird DT.
    Lancet; 1987 Dec 19; 2(8573):1415-8. PubMed ID: 2891991
    [Abstract] [Full Text] [Related]

  • 17. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
    Nilsson S, Zador G, Nygren KG, Wide L.
    Gynecol Obstet Invest; 1981 Dec 19; 12(4):203-10. PubMed ID: 7250783
    [Abstract] [Full Text] [Related]

  • 18. Methods to determine success of attempts to terminate early gestation pregnancies with prostaglandin vaginal suppositories.
    Brenner PF, Marrs RP, Roy S, Mishell DR.
    Contraception; 1983 Aug 19; 28(2):111-24. PubMed ID: 6196152
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Termination of early pregnancy by a single-dose 3.0 mg 15-methyl PGF2alpha methyl ester vaginal suppository.
    Mandelin M.
    Prostaglandins; 1978 Jul 19; 16(1):143-52. PubMed ID: 704921
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.